Bosnia & Herzegovina

Bosnia & Herzegovina is rapidly emerging as a resilient hub for pharmaceutical manufacturing and healthcare innovation within the Western Balkans.

The nation is best known for its robust pharmaceutical industry, anchored by regional leaders like Bosnalijek, which specialize in high-quality generic drugs and essential medicines for global export.

In the medical device sector, the country is gaining international recognition for its cost-effective production of diagnostic imaging equipment and non-invasive surgical tools, supported by a growing network of specialized SMEs.

Biotechnology research is gaining momentum through institutions like the Verlab Institute, which spearheads projects in digital health, molecular modeling and AI-driven diagnostics.

Academic excellence is centered at the University of Sarajevo, fostering interdisciplinary collaboration in biomedical sciences and genetics to align with European Research Area standards.

The healthcare system is undergoing significant modernization, with a strategic focus on clinical centers in Sarajevo, Banja Luka and Tuzla that are increasingly equipped with state-of-the-art US and EU medical technology.

Furthermore, the country is carving a niche in medical tourism, particularly in high-end dentistry and rehabilitation medicine, leveraging its European-trained workforce.

As the regulatory framework aligns with EU directives, Bosnia & Herzegovina offers a competitive landscape for life sciences investment and international research partnerships.